Search details
1.
Germline Elongator mutations in Sonic Hedgehog medulloblastoma.
Nature
; 580(7803): 396-401, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32296180
2.
The molecular landscape of ETMR at diagnosis and relapse.
Nature
; 576(7786): 274-280, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31802000
3.
LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.
BMC Cancer
; 24(1): 147, 2024 Jan 30.
Article
in English
| MEDLINE | ID: mdl-38291372
4.
Long-term use of everolimus for refractory arrhythmia in a child with tuberous sclerosis complex.
Am J Med Genet A
; 194(5): e63508, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38130096
5.
Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells.
J Neurooncol
; 166(1): 99-112, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38184819
6.
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines.
J Neurooncol
; 2024 Apr 17.
Article
in English
| MEDLINE | ID: mdl-38630384
7.
DNA methylation-based classification of central nervous system tumours.
Nature
; 555(7697): 469-474, 2018 03 22.
Article
in English
| MEDLINE | ID: mdl-29539639
8.
Group-specific cellular metabolism in Medulloblastoma.
J Transl Med
; 21(1): 363, 2023 06 05.
Article
in English
| MEDLINE | ID: mdl-37277823
9.
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.
Acta Neuropathol
; 145(6): 829-842, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37093271
10.
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma.
Acta Neuropathol
; 146(4): 551-564, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37656187
11.
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.
Acta Neuropathol
; 145(1): 97-112, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36459208
12.
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
Acta Neuropathol
; 145(1): 49-69, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36437415
13.
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
Acta Neuropathol
; 145(5): 667-680, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36933012
14.
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells.
J Neurooncol
; 164(3): 617-632, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37783879
15.
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.
J Neurooncol
; 165(3): 467-478, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37999877
16.
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
J Neurooncol
; 163(1): 143-158, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37183219
17.
A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsis.
Int J Cancer
; 151(4): 590-606, 2022 08 15.
Article
in English
| MEDLINE | ID: mdl-35411591
18.
Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing data.
Neuropathol Appl Neurobiol
; 47(3): 406-414, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33336421
19.
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies.
J Neurooncol
; 155(2): 193-202, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34657224
20.
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies.
BMC Cancer
; 20(1): 523, 2020 Jun 05.
Article
in English
| MEDLINE | ID: mdl-32503469